News FDA approves smartwatch for epilepsy monitoring A new smart watch which monitors for the most dangerous kinds of epileptic seizures, known as "grand mal" or "generalised tonic-clonic" seizures, has been approved by the FDA.
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.